0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Guaifenesin (API) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-10I2700
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Guaifenesin API Market Insights Forecast to 2026
BUY CHAPTERS

Global Guaifenesin (API) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-10I2700
Report
September 2022
115 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Guaifenesin (API) market is projected to reach US$ 98.3 million by 2028 from an estimated US$ 78 million in 2022, at a CAGR of 3.9% during 2023 and 2028.

Global Guaifenesin (API) key players include Granules, Synthokem Labs, Haizhou Pharma, Yuan Cheng Group, Stellar Chemical, etc. Global top five manufacturers hold a share about 65%. Asia-Pacific and North America is the largest market, both with a share about 35%, followed by Europe, with a share about 25 percent. In terms of product, Above 99% is the largest segment, with a share about 75%. And in terms of application, the largest application is Pharmaceuticals.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Guaifenesin (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Guaifenesin (API).
The Guaifenesin (API) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Guaifenesin (API) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Guaifenesin (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Seven Star Pharma
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm
Product Type Insights
Global markets are presented by Guaifenesin (API) type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Guaifenesin (API) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Guaifenesin (API) Segment by Type

98%-99%
Above 99%
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Guaifenesin (API) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Guaifenesin (API) market.

Guaifenesin (API) Segment by Application

Pharmaceuticals
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Guaifenesin (API) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Guaifenesin (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Guaifenesin (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Guaifenesin (API) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Guaifenesin (API)

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

1 Study Coverage
1.1 Guaifenesin (API) Product Introduction
1.2 Market by Type
1.2.1 Global Guaifenesin (API) Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 98%-99%
1.2.3 Above 99%
1.3 Market by Application
1.3.1 Global Guaifenesin (API) Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Pharmaceuticals
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Guaifenesin (API) Market Size Estimates and Forecasts
2.1.1 Global Guaifenesin (API) Revenue 2017-2028
2.1.2 Global Guaifenesin (API) Sales 2017-2028
2.2 Guaifenesin (API) Market Size by Region: 2022 Versus 2028
2.3 Guaifenesin (API) Sales by Region (2017-2028)
2.3.1 Global Guaifenesin (API) Sales by Region: 2017-2022
2.3.2 Global Guaifenesin (API) Sales Forecast by Region (2023-2028)
2.3.3 Global Guaifenesin (API) Sales Market Share by Region (2017-2028)
2.4 Guaifenesin (API) Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Guaifenesin (API) Revenue by Region: 2017-2022
2.4.2 Global Guaifenesin (API) Revenue Forecast by Region (2023-2028)
2.4.3 Global Guaifenesin (API) Revenue Market Share by Region (2017-2028)
3 Global Guaifenesin (API) by Manufacturers
3.1 Global Top Guaifenesin (API) Manufacturers by Sales
3.1.1 Global Guaifenesin (API) Sales by Manufacturer (2017-2022)
3.1.2 Global Guaifenesin (API) Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Guaifenesin (API) Manufacturers by Revenue
3.2.1 Global Guaifenesin (API) Revenue by Manufacturer (2017-2022)
3.2.2 Global Guaifenesin (API) Revenue Share by Manufacturer (2017-2022)
3.3 Global Guaifenesin (API) Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Guaifenesin (API) Manufacturers Covered: Ranking by Revenue
3.4.2 Global Guaifenesin (API) Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Guaifenesin (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Guaifenesin (API) Manufacturing Base Distribution, Product Type
3.5.1 Guaifenesin (API) Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Guaifenesin (API) Product Type
3.5.3 Date of International Manufacturers Enter into Guaifenesin (API) Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Granules
4.1.1 Granules Corporation Information
4.1.2 Granules Description, Business Overview
4.1.3 Granules Guaifenesin (API) Products Offered
4.1.4 Granules Guaifenesin (API) Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Granules Guaifenesin (API) Sales by Product in 2021
4.1.6 Granules Guaifenesin (API) Sales by Application in 2021
4.1.7 Granules Guaifenesin (API) Sales by Geographic Area in 2021
4.1.8 Granules Recent Developments
4.2 Synthokem Labs
4.2.1 Synthokem Labs Corporation Information
4.2.2 Synthokem Labs Description, Business Overview
4.2.3 Synthokem Labs Guaifenesin (API) Products Offered
4.2.4 Synthokem Labs Guaifenesin (API) Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Synthokem Labs Guaifenesin (API) Sales by Product in 2021
4.2.6 Synthokem Labs Guaifenesin (API) Sales by Application in 2021
4.2.7 Synthokem Labs Guaifenesin (API) Sales by Geographic Area in 2021
4.2.8 Synthokem Labs Recent Developments
4.3 Haizhou Pharma
4.3.1 Haizhou Pharma Corporation Information
4.3.2 Haizhou Pharma Description, Business Overview
4.3.3 Haizhou Pharma Guaifenesin (API) Products Offered
4.3.4 Haizhou Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Haizhou Pharma Guaifenesin (API) Sales by Product in 2021
4.3.6 Haizhou Pharma Guaifenesin (API) Sales by Application in 2021
4.3.7 Haizhou Pharma Guaifenesin (API) Sales by Geographic Area in 2021
4.3.8 Haizhou Pharma Recent Developments
4.4 Yuan Cheng Group
4.4.1 Yuan Cheng Group Corporation Information
4.4.2 Yuan Cheng Group Description, Business Overview
4.4.3 Yuan Cheng Group Guaifenesin (API) Products Offered
4.4.4 Yuan Cheng Group Guaifenesin (API) Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Yuan Cheng Group Guaifenesin (API) Sales by Product in 2021
4.4.6 Yuan Cheng Group Guaifenesin (API) Sales by Application in 2021
4.4.7 Yuan Cheng Group Guaifenesin (API) Sales by Geographic Area in 2021
4.4.8 Yuan Cheng Group Recent Developments
4.5 Stellar Chemical
4.5.1 Stellar Chemical Corporation Information
4.5.2 Stellar Chemical Description, Business Overview
4.5.3 Stellar Chemical Guaifenesin (API) Products Offered
4.5.4 Stellar Chemical Guaifenesin (API) Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Stellar Chemical Guaifenesin (API) Sales by Product in 2021
4.5.6 Stellar Chemical Guaifenesin (API) Sales by Application in 2021
4.5.7 Stellar Chemical Guaifenesin (API) Sales by Geographic Area in 2021
4.5.8 Stellar Chemical Recent Developments
4.6 Seven Star Pharma
4.6.1 Seven Star Pharma Corporation Information
4.6.2 Seven Star Pharma Description, Business Overview
4.6.3 Seven Star Pharma Guaifenesin (API) Products Offered
4.6.4 Seven Star Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Seven Star Pharma Guaifenesin (API) Sales by Product in 2021
4.6.6 Seven Star Pharma Guaifenesin (API) Sales by Application in 2021
4.6.7 Seven Star Pharma Guaifenesin (API) Sales by Geographic Area in 2021
4.6.8 Seven Star Pharma Recent Development
4.7 Gennex Lab
4.7.1 Gennex Lab Corporation Information
4.7.2 Gennex Lab Description, Business Overview
4.7.3 Gennex Lab Guaifenesin (API) Products Offered
4.7.4 Gennex Lab Guaifenesin (API) Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Gennex Lab Guaifenesin (API) Sales by Product in 2021
4.7.6 Gennex Lab Guaifenesin (API) Sales by Application in 2021
4.7.7 Gennex Lab Guaifenesin (API) Sales by Geographic Area in 2021
4.7.8 Gennex Lab Recent Development
4.8 Iwaki Seiyaku
4.8.1 Iwaki Seiyaku Corporation Information
4.8.2 Iwaki Seiyaku Description, Business Overview
4.8.3 Iwaki Seiyaku Guaifenesin (API) Products Offered
4.8.4 Iwaki Seiyaku Guaifenesin (API) Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Iwaki Seiyaku Guaifenesin (API) Sales by Product in 2021
4.8.6 Iwaki Seiyaku Guaifenesin (API) Sales by Application in 2021
4.8.7 Iwaki Seiyaku Guaifenesin (API) Sales by Geographic Area in 2021
4.8.8 Iwaki Seiyaku Recent Development
4.9 Pan Drugs
4.9.1 Pan Drugs Corporation Information
4.9.2 Pan Drugs Description, Business Overview
4.9.3 Pan Drugs Guaifenesin (API) Products Offered
4.9.4 Pan Drugs Guaifenesin (API) Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Pan Drugs Guaifenesin (API) Sales by Product in 2021
4.9.6 Pan Drugs Guaifenesin (API) Sales by Application in 2021
4.9.7 Pan Drugs Guaifenesin (API) Sales by Geographic Area in 2021
4.9.8 Pan Drugs Recent Development
4.10 Delta Synthetic
4.10.1 Delta Synthetic Corporation Information
4.10.2 Delta Synthetic Description, Business Overview
4.10.3 Delta Synthetic Guaifenesin (API) Products Offered
4.10.4 Delta Synthetic Guaifenesin (API) Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Delta Synthetic Guaifenesin (API) Sales by Product in 2021
4.10.6 Delta Synthetic Guaifenesin (API) Sales by Application in 2021
4.10.7 Delta Synthetic Guaifenesin (API) Sales by Geographic Area in 2021
4.10.8 Delta Synthetic Recent Development
4.11 Smart Pharm
4.11.1 Smart Pharm Corporation Information
4.11.2 Smart Pharm Description, Business Overview
4.11.3 Smart Pharm Guaifenesin (API) Products Offered
4.11.4 Smart Pharm Guaifenesin (API) Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Smart Pharm Guaifenesin (API) Sales by Product in 2021
4.11.6 Smart Pharm Guaifenesin (API) Sales by Application in 2021
4.11.7 Smart Pharm Guaifenesin (API) Sales by Geographic Area in 2021
4.11.8 Smart Pharm Recent Development
5 Breakdown Data by Type
5.1 Global Guaifenesin (API) Sales by Type (2017-2028)
5.1.1 Global Guaifenesin (API) Sales by Type (2017-2022)
5.1.2 Global Guaifenesin (API) Sales Forecast by Type (2023-2028)
5.1.3 Global Guaifenesin (API) Sales Market Share by Type (2017-2028)
5.2 Global Guaifenesin (API) Revenue Forecast by Type (2017-2028)
5.2.1 Global Guaifenesin (API) Revenue by Type (2017-2022)
5.2.2 Global Guaifenesin (API) Revenue Forecast by Type (2023-2028)
5.2.3 Global Guaifenesin (API) Revenue Market Share by Type (2017-2028)
5.3 Guaifenesin (API) Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Guaifenesin (API) Sales by Application (2017-2028)
6.1.1 Global Guaifenesin (API) Sales by Application (2017-2022)
6.1.2 Global Guaifenesin (API) Sales Forecast by Application (2023-2028)
6.1.3 Global Guaifenesin (API) Sales Market Share by Application (2017-2028)
6.2 Global Guaifenesin (API) Revenue Forecast by Application (2017-2028)
6.2.1 Global Guaifenesin (API) Revenue by Application (2017-2022)
6.2.2 Global Guaifenesin (API) Revenue Forecast by Application (2023-2028)
6.2.3 Global Guaifenesin (API) Revenue Market Share by Application (2017-2028)
6.3 Guaifenesin (API) Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Guaifenesin (API) Market Size YoY Growth 2017-2028
7.2 North America Guaifenesin (API) Market Facts & Figures by Country
7.2.1 North America Guaifenesin (API) Sales by Country (2017-2028)
7.2.2 North America Guaifenesin (API) Revenue by Country (2017-2028)
7.3 North America Guaifenesin (API) Sales by Type
7.4 North America Guaifenesin (API) Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Guaifenesin (API) Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Guaifenesin (API) Market Facts & Figures by Region
8.2.1 Asia-Pacific Guaifenesin (API) Sales by Region (2017-2028)
8.2.2 Asia-Pacific Guaifenesin (API) Revenue by Region (2017-2028)
8.3 Asia-Pacific Guaifenesin (API) Sales by Type
8.4 Asia-Pacific Guaifenesin (API) Sales by Application
9 Europe
9.1 Europe Guaifenesin (API) Market Size YoY Growth 2017-2028
9.2 Europe Guaifenesin (API) Market Facts & Figures by Country
9.2.1 Europe Guaifenesin (API) Sales by Country (2017-2028)
9.2.2 Europe Guaifenesin (API) Revenue by Country (2017-2028)
9.3 Europe Guaifenesin (API) Sales by Type
9.4 Europe Guaifenesin (API) Sales by Application
10 Latin America
10.1 Latin America Guaifenesin (API) Market Size YoY Growth 2017-2028
10.2 Latin America Guaifenesin (API) Market Facts & Figures by Country
10.2.1 Latin America Guaifenesin (API) Sales by Country (2017-2028)
10.2.2 Latin America Guaifenesin (API) Revenue by Country (2017-2028)
10.3 Latin America Guaifenesin (API) Sales by Type
10.4 Latin America Guaifenesin (API) Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Guaifenesin (API) Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Guaifenesin (API) Market Facts & Figures by Country
11.2.1 Middle East and Africa Guaifenesin (API) Sales by Country (2017-2028)
11.2.2 Middle East and Africa Guaifenesin (API) Revenue by Country (2017-2028)
11.3 Middle East and Africa Guaifenesin (API) Sales by Type
11.4 Middle East and Africa Guaifenesin (API) Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Guaifenesin (API) Supply Chain Analysis
12.2 Guaifenesin (API) Key Raw Materials and Upstream Suppliers
12.3 Guaifenesin (API) Clients Analysis
12.4 Guaifenesin (API) Sales Channel and Sales Model Analysis
12.4.1 Guaifenesin (API) Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Guaifenesin (API) Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Guaifenesin (API) Distributors
13 Market Dynamics
13.1 Guaifenesin (API) Industry Trends
13.2 Guaifenesin (API) Market Drivers
13.3 Guaifenesin (API) Market Challenges
13.4 Guaifenesin (API) Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Guaifenesin (API) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of 98%-99%
    Table 3. Major Manufacturers of Above 99%
    Table 4. Global Guaifenesin (API) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Guaifenesin (API) Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 6. Global Guaifenesin (API) Sales by Region (2017-2022) & (K MT)
    Table 7. Global Guaifenesin (API) Sales Forecast by Region (2023-2028) & (K MT)
    Table 8. Global Guaifenesin (API) Revenue by Region (2017-2022) & (US$ Million)
    Table 9. Global Guaifenesin (API) Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 10. Global Guaifenesin (API) Sales by Manufacturer (2017-2022) & (K MT)
    Table 11. Global Guaifenesin (API) Sales Share by Manufacturer (2017-2022)
    Table 12. Guaifenesin (API) Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 13. Guaifenesin (API) Revenue Share by Manufacturer (2017-2022)
    Table 14. Key Manufacturers Guaifenesin (API) Price (2017-2022) & (USD/MT)
    Table 15. Ranking of Global Top Guaifenesin (API) Manufacturers by Revenue (US$ Million) in 2021
    Table 16. Global Guaifenesin (API) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 17. Global Guaifenesin (API) by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Guaifenesin (API) as of 2021)
    Table 18. Guaifenesin (API) Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers Guaifenesin (API) Product Type
    Table 20. Date of International Manufacturers Enter into Guaifenesin (API) Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Granules Corporation Information
    Table 23. Granules Description and Business Overview
    Table 24. Granules Guaifenesin (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 25. Granules Guaifenesin (API) Product
    Table 26. Granules Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Product in 2021
    Table 27. Granules Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Application in 2021
    Table 28. Granules Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Geographic Area in 2021
    Table 29. Granules Recent Development
    Table 30. Synthokem Labs Corporation Information
    Table 31. Synthokem Labs Description and Business Overview
    Table 32. Synthokem Labs Guaifenesin (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 33. Synthokem Labs Guaifenesin (API) Product
    Table 34. Synthokem Labs Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Product in 2021
    Table 35. Synthokem Labs Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Application in 2021
    Table 36. Synthokem Labs Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Geographic Area in 2021
    Table 37. Synthokem Labs Recent Development
    Table 38. Haizhou Pharma Corporation Information
    Table 39. Haizhou Pharma Description and Business Overview
    Table 40. Haizhou Pharma Guaifenesin (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 41. Haizhou Pharma Guaifenesin (API) Product
    Table 42. Haizhou Pharma Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Product in 2021
    Table 43. Haizhou Pharma Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Application in 2021
    Table 44. Haizhou Pharma Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Geographic Area in 2021
    Table 45. Haizhou Pharma Recent Development
    Table 46. Yuan Cheng Group Corporation Information
    Table 47. Yuan Cheng Group Description and Business Overview
    Table 48. Yuan Cheng Group Guaifenesin (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 49. Yuan Cheng Group Guaifenesin (API) Product
    Table 50. Yuan Cheng Group Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Product in 2021
    Table 51. Yuan Cheng Group Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Application in 2021
    Table 52. Yuan Cheng Group Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Geographic Area in 2021
    Table 53. Yuan Cheng Group Recent Development
    Table 54. Stellar Chemical Corporation Information
    Table 55. Stellar Chemical Description and Business Overview
    Table 56. Stellar Chemical Guaifenesin (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 57. Stellar Chemical Guaifenesin (API) Product
    Table 58. Stellar Chemical Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Product in 2021
    Table 59. Stellar Chemical Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Application in 2021
    Table 60. Stellar Chemical Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Geographic Area in 2021
    Table 61. Stellar Chemical Recent Development
    Table 62. Seven Star Pharma Corporation Information
    Table 63. Seven Star Pharma Description and Business Overview
    Table 64. Seven Star Pharma Guaifenesin (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Seven Star Pharma Guaifenesin (API) Product
    Table 66. Seven Star Pharma Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Product in 2021
    Table 67. Seven Star Pharma Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Application in 2021
    Table 68. Seven Star Pharma Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Geographic Area in 2021
    Table 69. Gennex Lab Corporation Information
    Table 70. Gennex Lab Description and Business Overview
    Table 71. Gennex Lab Guaifenesin (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 72. Gennex Lab Guaifenesin (API) Product
    Table 73. Gennex Lab Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Product in 2021
    Table 74. Gennex Lab Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Application in 2021
    Table 75. Gennex Lab Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Geographic Area in 2021
    Table 76. Iwaki Seiyaku Corporation Information
    Table 77. Iwaki Seiyaku Description and Business Overview
    Table 78. Iwaki Seiyaku Guaifenesin (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 79. Iwaki Seiyaku Guaifenesin (API) Product
    Table 80. Iwaki Seiyaku Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Product in 2021
    Table 81. Iwaki Seiyaku Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Application in 2021
    Table 82. Iwaki Seiyaku Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Geographic Area in 2021
    Table 83. Pan Drugs Corporation Information
    Table 84. Pan Drugs Description and Business Overview
    Table 85. Pan Drugs Guaifenesin (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 86. Pan Drugs Guaifenesin (API) Product
    Table 87. Pan Drugs Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Product in 2021
    Table 88. Pan Drugs Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Application in 2021
    Table 89. Pan Drugs Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Geographic Area in 2021
    Table 90. Delta Synthetic Corporation Information
    Table 91. Delta Synthetic Description and Business Overview
    Table 92. Delta Synthetic Guaifenesin (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 93. Delta Synthetic Guaifenesin (API) Product
    Table 94. Delta Synthetic Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Product in 2021
    Table 95. Delta Synthetic Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Application in 2021
    Table 96. Delta Synthetic Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Geographic Area in 2021
    Table 97. Smart Pharm Corporation Information
    Table 98. Smart Pharm Description and Business Overview
    Table 99. Smart Pharm Guaifenesin (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 100. Smart Pharm Guaifenesin (API) Product
    Table 101. Smart Pharm Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Product in 2021
    Table 102. Smart Pharm Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Application in 2021
    Table 103. Smart Pharm Guaifenesin (API) Sales Proportion of Guaifenesin (API) by Geographic Area in 2021
    Table 104. Global Guaifenesin (API) Sales by Type (2017-2022) & (K MT)
    Table 105. Global Guaifenesin (API) Sales Forecast by Type (2023-2028) & (K MT)
    Table 106. Global Guaifenesin (API) Revenue by Type (2017-2022) & (US$ Million)
    Table 107. Global Guaifenesin (API) Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 108. Global Guaifenesin (API) Sales by Application (2017-2022) & (K MT)
    Table 109. Global Guaifenesin (API) Sales Forecast by Application (2023-2028) & (K MT)
    Table 110. Global Guaifenesin (API) Revenue by Application (2017-2022) & (US$ Million)
    Table 111. Global Guaifenesin (API) Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 112. North America Guaifenesin (API) Sales by Country (2017-2022) & (K MT)
    Table 113. North America Guaifenesin (API) Sales by Country (2023-2028) & (K MT)
    Table 114. North America Guaifenesin (API) Revenue by Country (2017-2022) & (US$ Million)
    Table 115. North America Guaifenesin (API) Revenue by Country (2023-2028) & (US$ Million)
    Table 116. North America Guaifenesin (API) Sales by Type (2017-2022) & (K MT)
    Table 117. North America Guaifenesin (API) Sales by Application (2017-2022) & (K MT)
    Table 118. Asia-Pacific Guaifenesin (API) Sales by Region (2017-2022) & (K MT)
    Table 119. Asia-Pacific Guaifenesin (API) Sales by Region (2023-2028) & (K MT)
    Table 120. Asia-Pacific Guaifenesin (API) Revenue by Region (2017-2028) & (US$ Million)
    Table 121. Asia-Pacific Guaifenesin (API) Revenue by Region (2023-2028) & (US$ Million)
    Table 122. Asia-Pacific Guaifenesin (API) Sales by Type (2017-2022) & (K MT)
    Table 123. Asia-Pacific Guaifenesin (API) Sales by Application (2017-2022) & (K MT)
    Table 124. Europe Guaifenesin (API) Sales by Country (2017-2022) & (K MT)
    Table 125. Europe Guaifenesin (API) Sales by Country (2023-2028) & (K MT)
    Table 126. Europe Guaifenesin (API) Revenue by Country (2017-2022) & (US$ Million)
    Table 127. Europe Guaifenesin (API) Revenue by Country (2023-2028) & (US$ Million)
    Table 128. Europe Guaifenesin (API) Sales by Type (2017-2022) & (K MT)
    Table 129. Europe Guaifenesin (API) Sales by Application (2017-2022) & (K MT)
    Table 130. Latin America Guaifenesin (API) Sales by Country (2017-2022) & (K MT)
    Table 131. Latin America Guaifenesin (API) Sales by Country (2023-2028) & (K MT)
    Table 132. Latin America Guaifenesin (API) Revenue by Country (2017-2022) & (US$ Million)
    Table 133. Latin America Guaifenesin (API) Revenue by Country (2023-2028) & (US$ Million)
    Table 134. Latin America Guaifenesin (API) Sales by Type (2017-2022) & (K MT)
    Table 135. Latin America Guaifenesin (API) Sales by Application (2017-2022) & (K MT)
    Table 136. Middle East and Africa Guaifenesin (API) Sales by Country (2017-2022) & (K MT)
    Table 137. Middle East and Africa Guaifenesin (API) Sales by Country (2023-2028) & (K MT)
    Table 138. Middle East and Africa Guaifenesin (API) Revenue by Country (2017-2022) & (US$ Million)
    Table 139. Middle East and Africa Guaifenesin (API) Revenue by Country (2023-2028) & (US$ Million)
    Table 140. Middle East and Africa Guaifenesin (API) Sales by Type (2017-2022) & (K MT)
    Table 141. Middle East and Africa Guaifenesin (API) Sales by Application (2017-2022) & (K MT)
    Table 142. Guaifenesin (API) Key Raw Materials, Industry Status and Trend
    Table 143. Guaifenesin (API) Key Raw Materials and Upstream Suppliers
    Table 144. Guaifenesin (API) Clients Status and Trend
    Table 145. Guaifenesin (API) Typical Clients
    Table 146. Guaifenesin (API) Distributors
    Table 147. Guaifenesin (API) Market Trends
    Table 148. Guaifenesin (API) Market Drivers
    Table 149. Guaifenesin (API) Market Challenges
    Table 150. Guaifenesin (API) Market Restraints
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Guaifenesin (API) Product Picture
    Figure 2. Global Guaifenesin (API) Sales Market Share by Type in 2021 & 2028
    Figure 3. 98%-99% Product Picture
    Figure 4. Above 99% Product Picture
    Figure 5. Global Guaifenesin (API) Sales Market Share by Application in 2021 & 2028
    Figure 6. Pharmaceuticals Examples
    Figure 7. Others Examples
    Figure 8. Guaifenesin (API) Report Years Considered
    Figure 9. Global Guaifenesin (API) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Guaifenesin (API) Market Size 2017-2028 (US$ Million)
    Figure 11. Global Guaifenesin (API) Sales 2017-2028 (K MT)
    Figure 12. Global Guaifenesin (API) Market Size Market Share by Region: 2022 Versus 2028
    Figure 13. Global Guaifenesin (API) Sales Market Share Forecast by Region (2017-2028)
    Figure 14. Global Guaifenesin (API) Revenue Market Share by Region (2017-2028)
    Figure 15. Global Guaifenesin (API) Sales Share by Manufacturer in 2021
    Figure 16. Guaifenesin (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Guaifenesin (API) Sales Market Share Forecast by Type (2017-2028)
    Figure 18. Global Guaifenesin (API) Revenue Market Share Forecast by Type (2017-2028)
    Figure 19. Guaifenesin (API) Average Selling Price (ASP) by Type (2017-2022) & (USD/MT)
    Figure 20. Global Guaifenesin (API) Sales Market Share Forecast by Application (2017-2028)
    Figure 21. Global Guaifenesin (API) Revenue Market Share Forecast by Application (2017-2028)
    Figure 22. Guaifenesin (API) Average Selling Price (ASP) by Application (2017-2022) & (USD/MT)
    Figure 23. North America Guaifenesin (API) Revenue 2017-2028 (US$ Million)
    Figure 24. North America Guaifenesin (API) Sales Market Share by Type (2017-2022)
    Figure 25. North America Guaifenesin (API) Sales Market Share by Application (2017-2022)
    Figure 26. Asia-Pacific Guaifenesin (API) Revenue 2017-2028 (US$ Million)
    Figure 27. Asia-Pacific Guaifenesin (API) Sales Market Share by Region (2017-2028)
    Figure 28. Asia-Pacific Guaifenesin (API) Revenue Market Share by Region (2017-2028)
    Figure 29. Asia-Pacific Guaifenesin (API) Sales Market Share by Type (2017-2022)
    Figure 30. Asia-Pacific Guaifenesin (API) Sales Market Share by Application (2017-2022)
    Figure 31. Europe Guaifenesin (API) Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 32. Europe Guaifenesin (API) Sales Market Share by Country (2017-2028)
    Figure 33. Europe Guaifenesin (API) Revenue Market Share by Country (2017-2028)
    Figure 34. Europe Guaifenesin (API) Sales Market Share by Type (2017-2022)
    Figure 35. Europe Guaifenesin (API) Sales Market Share by Application (2017-2022)
    Figure 36. Latin America Guaifenesin (API) Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 37. Latin America Guaifenesin (API) Sales Market Share by Country (2017-2028)
    Figure 38. Latin America Guaifenesin (API) Revenue Market Share by Country (2017-2022)
    Figure 39. Latin America Guaifenesin (API) Sales Market Share by Type (2017-2022)
    Figure 40. Latin America Guaifenesin (API) Sales Market Share by Application (2017-2022)
    Figure 41. Middle East and Africa Guaifenesin (API) Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 42. Middle East and Africa Guaifenesin (API) Sales Market Share by Country (2017-2028)
    Figure 43. Middle East and Africa Guaifenesin (API) Revenue Market Share by Country (2017-2028)
    Figure 44. Middle East and Africa Guaifenesin (API) Sales Market Share by Type (2017-2022)
    Figure 45. Middle East and Africa Guaifenesin (API) Sales Market Share by Application (2017-2022)
    Figure 46. Guaifenesin (API) Supply Chain (Upstream and Downstream Market)
    Figure 47. Global Production Market Share of Guaifenesin (API) Raw Materials by Region in 2021
    Figure 48. Guaifenesin (API) Distribution Channels
    Figure 49. Global Guaifenesin (API) Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 50. Global Guaifenesin (API) Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona
SIMILAR REPORTS